Takeda has ended the manufacturing and supply of its gout drug Uloric in the US market as more patients turn to generic ...

Novo Nordisk, Eli Lilly, and others are advancing obesity drugs, with key data expected for assets including CagriSema, ...

AstraZeneca is looking to increase its presence north of the US border. The UK pharma said it is budgeting $570 million to ...

Moderna’s chief information officer Brad Miller is 'retiring' in February, a company spokesperson confirmed to Endpoints News ...

Novo Nordisk’s subcutaneous form of amycretin achieved estimated weight loss of 22% at six months in a Phase 1b/2a clinical ...

ALX Oncology is forging ahead with a treatment approach that has long been abandoned by other drugmakers, eyeing a potential ...

Boehringer Ingelheim merges AMAL and ViraTherapeutics cancer units, Dantari sells assets to Adanate, Madrona raises $770M, and Abdera adds JJDC and Foresite as investors.

Teva, Astellas and AstraZeneca say they will participate in the next round of Medicare negotiations under the Inflation ...

UnitedHealth Group has named a new CEO to lead its health insurance business, following the murder of the division’s former ...

Aardvark Therapeutics files for IPO. Company develops hunger-targeting obesity drug ARD-101 and ARD-201, led by CEO Tien Lee.

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement in a longstanding legal battle over the ...

What will President Donald Trump's team do on healthcare? Nobody knows for sure. That was the general agreement among the policy experts who advise the drug industry last week at the JP Morgan ...